Organogenesis Holdings Inc. (ORGO) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 4 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ORGO is $9.00, representing a +258.6% upside from the current price of $2.51. Price targets range from a low of $9.00 to a high of $9.00.
